Palatin Technologies, Inc. (LON:0KF3)
London · Delayed Price · Currency is GBP · Price in USD 6.50
-1.15 (-15.03%)
Oct 16, 2026, 5:12 PM GMT
Palatin Technologies Market Cap
Palatin Technologies has a market cap or net worth of 8.67 million as of October 16, 2026. It is the 39,600th most valuable company in the world and the 870th biggest in the United Kingdom. Its market cap has increased by 45.95% in one year.
Market Cap
8.67M
Enterprise Value
3.14M
Revenue
9.94M
Global Rank
Country Rank
#870 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since January 29, 2018, Palatin Technologies's market cap has decreased from 124.07M to 8.67M, a decrease of -93.02%. That is a compound annual growth rate of -26.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 8.67M | -75.35% |
| Dec 11, 2025 | 35.16M | 61.85% |
| Dec 31, 2024 | 21.72M | -43.72% |
| Dec 29, 2023 | 38.60M | 99.29% |
| Dec 28, 2022 | 19.37M | -79.00% |
| Dec 30, 2021 | 92.25M | -28.03% |
| Dec 28, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oxford BioDynamics | 15.35M |
| IXICO | 15.33M |
| SkinBioTherapeutics | 15.03M |
| Thalia Therapeutics | 11.32M |
| Aptamer Group | 10.99M |
| Genflow Biosciences | 9.95M |
| Fusion Antibodies | 8.14M |
| Solvonis Therapeutics | 7.03M |